1-9 of 9
Maria Teresa Cibeira, MD PhD
Close
Sort by
Journal Articles

Smoldering Multiple Myeloma: Usefulness of Serum Heavy/Light Chain Measurements for the Evaluation of Evolving Pattern

Carlos Fernandez de Larrea, MD PhD, Ignacio Isola, MD, Esther Moga, Maria Teresa Cibeira, MD PhD, Ester Lozano, PhD, Juan I. Arostegui, Montserrat Elena, Natalia Tovar, MD PhD, Jordi Yague, Laura Rosinol, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4514.
https://doi.org/10.1182/blood-2018-99-117385
Published: 2018
Journal Articles

VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Laura Rosinol Dachs, Albert Oriol, MD, Ana Isabel Teruel, MDcal Doctor, Ana López de la Guía, M Jesús Blanchard, Isidro Jarque, Miquel Granell, MD, Antonia Sampol, Luis Palomera, MD PhD, Yolanda Gonzalez-Montes, Enrique Bengoechea, Rafael Martínez-Martínez, Miguel T Hernández, MD PhD, Felipe De Arriba, PhD, Maria Luisa Martin-Ramos, Norma C. Gutierrez, MD PhD, Maria Teresa Cibeira, MD PhD, Maria-Victoria Mateos, MD PhD, Joaquin Martinez-Lopez, MD PhD, Adrián Alegre, MD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD, Joan Blade, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 126.
https://doi.org/10.1182/blood-2018-99-111924
Published: 2018
Journal Articles

Survival Improvement in the Last 45 Years in Patients with Multiple Myeloma: Real-World Data from a Single Center

Luis Gerardo Rodríguez-Lobato, MD PhD, Carlos Fernández De Larrea, MD PhD, Natalia Tovar, MD PhD, Maria Teresa Cibeira, MD PhD, Joan Bladé, MD PhD, Laura Rosinol, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5573.
https://doi.org/10.1182/blood-2018-99-112089
Published: 2018
Journal Articles

Mir-485-3p and Mir-654-3p Expression in Bone Marrow Mesenchymal Stromal Cells in Patients with Monoclonal Gammopathies Is Related to the Status of the Disease

Carlos Fernandez de Larrea, MD PhD, Tania Diaz, PhD, Alfons Navarro, PhD, Ester Lozano, PhD, Mari-Pau Mena, PhD, Ignacio Isola, MD, Natalia Tovar, MD PhD, Maria Teresa Cibeira, MD PhD, Laura Rosinol, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3155.
https://doi.org/10.1182/blood-2018-99-112222
Published: 2018
Journal Articles

Natural History of Asymptomatic IgM Monoclonal Gammopathies: Impact of the Bone Marrow Aspiration into the Classification and Prognosis

Carlos Fernandez de Larrea, MD PhD, David Moreno, MD, Natalia Tovar, MD PhD, Maria Teresa Cibeira, MD PhD, Ignacio Isola, MD, Laura Magnano, MD, Laura Rosinol, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1610.
https://doi.org/10.1182/blood-2018-99-115038
Published: 2018
Journal Articles

Incidence and Outcome of Soft-Tissue Plasmacytomas in Patients with Multiple Myeloma before and after the Introduction of Novel Drugs

Raquel Jiménez, MD, Laura Rosinol, MD PhD, Maria Teresa Cibeira, MD PhD, Carlos Fernández De Larrea, MD PhD, Esther Blade, Natalia Tovar, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3140.
https://doi.org/10.1182/blood.V130.Suppl_1.3140.3140
Published: 2017
Journal Articles

Salvage Therapy for Multiple Myeloma with Lenalidomide-Based Regimens: Impact of Single Nucleotide Polymorphisms Related to miRNA Pathways

Carlos Fernández de Larrea, MD PhD, Tania Díaz, PhD, María Teresa Cibeira, MD PhD, Natalia Tovar, MD, Alfons Navarro, PhD, Laura Rosiñol, MD PhD, Raquel Jiménez, MD, Rut Tejero, PhD, Mariano Monzó, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2045.
https://doi.org/10.1182/blood.V124.21.2045.2045
Published: 2014
Journal Articles

Smoldering Multiple Myeloma: Impact of the Evolving Pattern on Early Progression

Carlos Fernández de Larrea, MD PhD, Ignacio Isola, MD, María Teresa Cibeira, MD PhD, Laura Rosiñol, MD PhD, Xavier Calvo, MD, Natalia Tovar, MD, Montserrat Elena, MD, Laura Magnano, MD, Juan I. Aróstegui, MD PhD, María Rozman, MD PhD, Jordi Yagüe, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3363.
https://doi.org/10.1182/blood.V124.21.3363.3363
Published: 2014
Journal Articles

Prognostic Impact Of Serum Heavy/Light Chain Pairs In Patients With MGUS and Smoldering Myeloma: Long-Term Results From a Single Institution

Carlos Fernández de Larrea, MD, PhD, Laura Magnano, MD, Montserrat Elena, MD, María Teresa Cibeira, MD, PhD, Natalia Tovar, MD, Juan I. Aróstegui, MD, PhD, Fabiola Pedrosa, MS, Laura Rosiñol, MD, Xavier Filella, MD, PhD, Jordi Yagüe, MD, PhD, Joan Bladé, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3132.
https://doi.org/10.1182/blood.V122.21.3132.3132
Published: 2013